rss
Postgrad Med J 2005;81:117-121 doi:10.1136/pgmj.2004.018705
  • Original article

Study of familial Parkinson’s disease in Russia, Uzbekistan, and Zambia

  1. M Atadzhanov1,
  2. A Zumla2,
  3. P Mwaba1
  1. 1Department of Medicine, University of Zambia School of Medicine, University Teaching Hospital, Lusaka, Zambia
  2. 2Department of Medicine, University of Zambia School of Medicine, University Teaching Hospital, Lusaka, Zambia and Windeyer Institute of Medical Sciences, University College London, London, UK
  1. Correspondence to:
 Professor Masharip Atadzhanov
 Department of Medicine, University of Zambia School of Medicine, PO Box 50110, University Teaching Hospital, Lusaka, Zambia; masharipyahoo.com
  • Received 31 December 2003
  • Accepted 1 April 2004

Abstract

Objective: The aims of this study were (A) to determine inheritance patterns of familial Parkinson’s disease in three different geographical areas (Russia, Uzbekistan, and Zambia); (B) compare clinical characteristics of familial with sporadic Parkinson’s disease; and (C) assess whether there were ethnic differences in clinical manifestations of the disease.

Methods: Fifty two index cases of familial Parkinson’s disease in Moscow, 55 in Tashkent, and 27 in Lusaka were selected on the basis of the typical clinical features of Parkinson’s disease with a familial history. The sex ratio, transmission patterns, and segregation ratio were determined by pedigree analysis.

Results: Familial Parkinson’s disease was found in all three countries (30 families in Russia, 12 in Uzbekistan, and seven in Zambia), and appeared more common in Russia. Both autosomal dominant and autosomal recessive patterns of inheritance were seen, but autosomal dominance was more common in all countries.

Conclusions: In all three countries men have a higher risk of developing Parkinson’s disease than women and there are ethnic differences in clinical manifestations of the disease. The onset of both familial and sporadic Parkinson’s disease in Zambian patients occurs at a younger age and is associated with slow progression and a benign course, and generally responds well to levodopa treatment.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.